Top compounds associated with response to MYBL2


Feature Type Standardized
Nominal ANOVA
mRNA MST-312 CTRPv2 pan-cancer AAC 0.081 0.03
mRNA decitabine CTRPv2 pan-cancer AAC 0.063 0.03
mRNA lapatinib GDSC1000 pan-cancer AAC -0.11 0.03
mRNA ML258 CTRPv2 pan-cancer AAC 0.086 0.03
mRNA Nutlin-3 CTRPv2 pan-cancer AAC -0.079 0.03
mRNA AZD-7545 CTRPv2 pan-cancer AAC 0.083 0.03
mRNA Docetaxel CTRPv2 pan-cancer AAC 0.11 0.03
mRNA Methotrexate CTRPv2 pan-cancer AAC 0.084 0.03
mRNA Compound 7d-cis CTRPv2 pan-cancer AAC 0.082 0.03
mRNA VAF-347 CTRPv2 pan-cancer AAC -0.11 0.03
Download CSV